Related Experiment Video
Updated: May 6, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
10.5K
Jaundice and kernicterus in the moderately preterm infant
Matthew B Wallenstein1, Vinod K Bhutani
1Division of Neonatal-Developmental Medicine, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University School of Medicine, 750 Welch Road #315, Stanford, CA 94304, USA.
Clinics in Perinatology
|November 5, 2013
Summary
Moderate preterm infants face risks from high bilirubin levels, potentially causing brain damage. This review offers strategies to optimize hyperbilirubinemia management in these infants, aligning with new guidelines to prevent kernicterus.
Area of Science:
- Neonatology
- Pediatric Neurology
- Clinical Management
Background:
- Moderate preterm infants (<35 weeks gestation) have increased risks for adverse outcomes.
- Hyperbilirubinemia (high bilirubin levels) can lead to acute bilirubin encephalopathy (ABE) and kernicterus.
- Current evidence-based guidelines for managing hyperbilirubinemia in this population are suboptimal.
Purpose of the Study:
- To outline clinical strategies for managing hyperbilirubinemia in moderately preterm infants.
- To operationalize recent consensus-based recommendations for this vulnerable group.
- To reduce the risk of adverse neurologic outcomes, including ABE and kernicterus.
Main Methods:
- Review of current literature and clinical guidelines.
- Analysis of ABE clinical manifestations in preterm versus term infants.
- Development of practical strategies for implementing consensus recommendations.
Main Results:
- Clinical signs of ABE in preterm infants are often subtle compared to term infants.
- Optimized management strategies are crucial for preventing bilirubin-induced neurotoxicity.
- Consensus-based recommendations provide a framework for improved clinical practice.
Conclusions:
- Implementing evidence-based strategies is essential for managing hyperbilirubinemia in moderately preterm infants.
- Early and effective intervention can mitigate the risk of permanent neurologic sequelae.
- This review provides a practical approach to meet updated management recommendations.
Related Concept Videos
01:25Jaundice
48
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
48
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
01:14Changes in Skin Color: Clinical Perspectives
3.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:26Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
01:24Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53